Reduced Changes In Bone Mineral Density In CHB Patients Receiving Tenofovir Alfenamide (TAF) Compared With Tenofovir disoproxil fumarate

被引：0
|
作者：
Seto, Wai-Kay [2 ]
Asahina, Yasuhiro [3 ]
Peng, Cheng-Yuan [4 ]
Stanciu, Carol [5 ]
Abdurakhmanov, Djamal [6 ]
Flaherty, John F. [1 ]
Kim, Kyungpil [1 ]
Gaggar, Anuj [1 ]
Subramanian, Mani [1 ]
Tabak, Fehmi [7 ]
Nguyen, Tuan T. [8 ]
Chan, Henry Lik-Yuen [9 ]
机构：
[1] Gilead Sci, Foster City, CA USA
[2] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[3] Tokyo Med & Dent Univ, Gastroenterol & Hepatol, Tokyo, Japan
[4] China Med Univ Hosp, Div Hepatogastroenterol, Dept Internal Med, Taichung, Taiwan
[5] Univ Med & Pharm Gr T Popa, Inst Gastroenterol & Hepatol, Iasi, Romania
[6] Univ Clin Hosp 1, Moscow, Russia
[7] Istanbul Univ, Cerrahpassa Tip Fak Hastanesi, Infect Dis, Istanbul, Turkey
[8] Res & Educ Inc, San Diego, CA USA
[9] Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
67
引用
收藏
页码：35A / 35A
页数：1
相关论文
共 50 条
  • [41] Eligibility of patients in a community HIV setting for switching rilpivirine/emtricitabine/tenofovir disoproxil fumarate (R/F/TDF) to tenofovir alafenamide(TAF)
    Goorney, B.
    Perez, K.
    HIV MEDICINE, 2019, 20 : 39 - 39
  • [42] Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s
    Gupta, Samir K.
    Yeh, Eunice
    Kitch, Douglas W.
    Brown, Todd T.
    Venuto, Charles S.
    Morse, Gene D.
    Ha, Belinda
    Melbourne, Kathleen
    McComsey, Grace A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (07) : 2042 - 2048
  • [43] Tenofovir Disoproxil Fumarate/Emtricitabine Prophylaxis Has No Effect on Bone Mineral Density and Bone Mineral Content in African Breastfeeding Women Receiving Pre-Exposure Prophylaxis for HIV
    Kistan, Gaysheen
    Sebitloane, Motshedisi
    Lombard, Carl
    Godlwana, Zukiswa
    Desmond, Alicia C.
    Clark, Richard
    Rooney, James F.
    Gray, Glenda
    Moodley, Dhayendre
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2025, 98 (03) : 265 - 273
  • [44] A phase 3 study comparing tenofovir alafenamide (TAF) to tenofovir disoproxil fumarate (TDF) in patients with HBeAg-positive, chronic hepatitis B (CHB): efficacy and safety results at week 96
    Agarwal, K.
    Fung, S.
    Seto, W. K.
    Lim, Y. S.
    Gane, E.
    Janssen, H. L.
    Sharma, M.
    Chuang, W. L.
    Bae, H.
    Yoon, K. T.
    Flaherty, J. F.
    Lau, A.
    Gaggar, A.
    Suri, V.
    Cathcart, A.
    Lin, L.
    Subramanian, G. M.
    Shalimar
    Furusyo, N.
    Buti, M.
    Chan, H. L.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S478 - S478
  • [45] IMPROVEMENT OF BONE MINERAL DENSITY AND MARKERS OF PROXIMAL RENAL TUBULAR FUNCTION IN 12 WEEKS IN CHRONIC HEPATITIS B PATIENTS SWITCHED FROM TENOFOVIR DISOPROXIL FUMARATE TO TENOFOVIR ALAFENAMIDE
    Fong, Tse-Ling
    Lee, Brian T.
    Tien, Andy
    Le, Justin
    Ahn, Aiden
    Kim, Carolina
    Chang, Mimi
    Bae, Ho
    GASTROENTEROLOGY, 2018, 154 (06) : S1133 - S1134
  • [46] Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B
    Chan, Henry Lik Yuen
    Lim, Young-Suk
    Seto, Wai Kay Walter
    Agarwal, Kosh
    Brunetto, Maurizia R.
    Janssen, Harry L. A.
    Caruntu, Florin
    Stepanova, Tatjana
    Tsang, Owen
    Yatsuhashi, Hiroshi
    Tak, Won Young
    Chen, Chi-Yi
    Celen, Mustafa
    Suri, Vithika
    Flaherty, John F.
    Lin, Lanjia
    Cathcart, Andrea
    Gaggar, Anuj
    Pan, Calvin Q.
    Shalimar
    Buti, Maria
    HEPATOLOGY, 2018, 68 : 227A - 228A
  • [47] Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir
    Brown, Todd T.
    Moser, Carlee
    Currier, Judith S.
    Ribaudo, Heather J.
    Rothenberg, Jennifer
    Kelesidis, Theodoros
    Yang, Otto
    Dube, Michael P.
    Murphy, Robert L.
    Stein, James H.
    McComsey, Grace A.
    JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (08): : 1241 - 1249
  • [48] WEEK 96 EFFICACY AND SAFETY RESULTS OF TENOFOVIR ALAFENAMIDE (TAF) COMPARING TO TENOFOVIR DISOPROXIL FUMARATE (TDF) IN CHRONIC HEPATITIS B (CHB), HBEAG-POSITIVE PATIENTS: A GLOBAL PHASE 3 STUDY
    Agarwal, Kosh
    Fung, Scott
    Seto, Wai-Kay
    Lim, Young-Suk
    Gane, Edward
    Janssen, Harry L.
    Chuang, Wan-Long
    Bae, Ho
    Yoon, Ki Tae
    Flaherty, John F.
    Lau, Audrey
    Gaggar, Anuj
    Suri, Vithika
    Cathcart, Andrea
    Lin, Lanjia
    Chan, Alain
    Shalimar, Mani Subramanian
    Furusyo, Norihiro
    Buti, Maria
    Chan, Henry L.
    GASTROENTEROLOGY, 2017, 152 (05) : S1085 - S1086
  • [49] CORRELATIONS BETWEEN NON-INVASIVE BIOMARKERS AND FIBROSIS SCORES IN CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) AND TENOFOVIR ALAFENAMIDE (TAF) IN PHASE 3 CLINICAL TRIALS
    Ferret, Maria Asuncion Buti
    Gane, Edward J.
    Marcellin, Patrick
    Jacobson, Ira M.
    Janssen, Harry L. A.
    Agarwal, Kosh
    Fung, Scott K.
    Chuang, Wan-Long
    Pan, Calvin
    Flaherty, John F.
    Wang, Hongyuan
    Tan, Susanna
    Suri, Vithika
    Gaggar, Anuj
    Limw, Young-Suk
    Chan, Henry Lik Yuen
    HEPATOLOGY, 2020, 72 : 479A - 480A
  • [50] IMPACT OF LONG- TERM TREATMENT WITH CONTINUOUS TENOFOVIR ALAFENAMIDE ( TAF) OR AFTER SWITCH FROM TENOFOVIR DISOPROXIL FUMARATE ( TDF) ON HEPATOCELLULAR CARCINOMA ( HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B ( CHB)
    Lim, Young-Suk
    Wong, Grace Lai-Hung C.
    Ahn, Sang Hoon
    Seto, Wai-Kay
    Agarwal, Kosh
    Janssen, Harry L. A.
    Pan, Calvin Q.
    Chuang, Wan Long
    Fung, Scott K.
    Shalimar
    Brunetto, Maurizia R.
    Hui, Aric Josun
    Chang, Ting-Tsung
    Lim, Seng Gee
    Abramov, Frida
    Flaherty, John F.
    Wang, Hongyuan
    Yee, Leland J.
    Kao, Jia-Horng
    Marcellin, Patrick
    Gane, Edward J.
    Buti, Maria
    HEPATOLOGY, 2023, 78 : S523 - S526
12345